By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

Science Briefing

Science Briefing

Science Briefing

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Hematology - The Genetic Blueprint of Reproductive Failure: A Massive Cohort Study

Hematology

The Genetic Blueprint of Reproductive Failure: A Massive Cohort Study

Last updated: February 15, 2026 7:43 am
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE

The Genetic Blueprint of Reproductive Failure: A Massive Cohort Study

A landmark retrospective study of over 227,000 couples seeking assisted reproductive technology (ART) has provided a detailed epidemiological map of chromosomal aberrations linked to reproductive failure. The research, published in *Human Reproduction*, found an overall prevalence of 3.42%, with the highest rates in couples with a history of adverse pregnancy outcomes (4.83%). Key stratified risks emerged: a higher prevalence was observed in younger individuals, men with poorer semen quality (rising to 12.54% in azoospermia), and those with multiple adverse pregnancy events. The most common findings included reciprocal translocations, with recurrent breakpoints at 11q23 and 22q11, and aneuploidies like Klinefelter (47,XXY) and Turner (45,X) syndromes.

Why it might matter to you: For hematologists, this study’s methodology in large-scale cytogenetic analysis and risk stratification is directly analogous to investigating clonal hematopoiesis and myeloid neoplasms. The identification of recurrent chromosomal breakpoints and the correlation between aberration prevalence and specific clinical parameters (like semen quality) offer a model for refining risk assessment in pre-leukemic conditions. This evidence supports the critical role of systematic genetic screening prior to major clinical interventions, a principle that is central to modern hematologic practice, especially in the context of bone marrow failure and myelodysplastic syndromes.

Source →

Stay curious. Stay informed — with Science Briefing.

Always double check the original article for accuracy.

- Advertisement -

Feedback

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article Blood Pressure’s Double-Edged Sword: Unpacking the Link Between Hypertension and Chronic Pain
Next Article The Limits of Potency: High-Efficacy Therapies and Silent Progression in MS
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

Acknowledging the Unseen Pillars of Pathology

No Directly Relevant Hematology Research Found in This Batch

A New Standard for Preventing Infection in Neuroendovascular Procedures

A Deeper Look at the Brain’s Wiring in Depression

The Iron-Fueled Heart: How a New Form of Cell Death Drives Heart Failure

A Diagnostic Pitfall: Intraductal Histiocytes Mimicking Prostate Cancer

DNA Blueprints Reveal Survival Clues in a Common Brain Cancer

Weekly Journal Scan: VESALIUS-CV extends PCSK9 inhibition to the prevention of first major cardiovascular events

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Social Sciences
  • Energy
  • Gastroenterology
  • Surgery
  • Natural Language Processing
  • Chemistry
  • Engineering
  • Neurology

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?